The partnership is working to advance affordable, new antivirals and vaccines for neglected infectious diseases such as the dengue, Zika and Chikungunya viruses.
The SUNY Distinguished Professor is the recipient of the 2020 Distinguished Pharmaceutical Scientist Award from the American Association of Pharmaceutical Sciences.
When a corporation’s earnings are steady, its board of directors is more likely to fire its CEO after a bad earnings period, new UB research has found.
UB spinoff Cytocybernetics is developing a tool to rapidly assess if investigational COVID-19 drugs have properties that can result in sudden cardiac death.